India has announced positive late-stage clinical results from its first indigenous oral rotavirus vaccine developed through a unique public-private partnership.
The vaccine, if approved by the national regulator, is expected to be priced at $1 per dose, far cheaper than...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
